Abstract
To investigate the safety and effectiveness of the Phoenix atherectomy device for the treatment of complex and calcified lesions in patients with peripheral artery disease (PAD). 136 consecutive all-comer patients with chronic PAD underwent Phoenix atherectomy. Safety in terms of vessel injury and embolism, efficacy and clinical success in terms of ≥ 1Rutherford class (RF) improvement during follow-up were systematically analyzed. Lesion calcification was categorized by the Peripheral Arterial Calcium Scoring System (PACSS), whereas lesion complexity was classified by the Transatlantic Inter-Society Consensus (TASC). 151 lesions were treated in 136 consecutive patients. Clinical follow-up was available at 10.3 ± 4.2 months in 132 (97%) patients. 55 patients (40%) had intermittent claudication, 16 (12%) rest pain and 65 (48%) had ischemic ulcerations (mean RF class = 4.2 ± 1.1). 15 (11%) patients had TASC B lesions, whereas the majority 72 (53%) and 49 (36%) exhibited TASC C and D lesions, respectively. Mean PACSS score was 3.3 ± 0.9. Mean lesion length was 106 ± 92 mm. Atherectomy was combined with drug-coated balloon (DCB) in 129 (95%) patients. Nine (6.6%) patients with infra-inguinal lesions received stents. Technical and procedural success were recorded in 102 (75%) and 135 (99%), respectively. Perforation was noticed in 2 (1%), whereas asymptomatic embolism occurred in 6 (4%) patients. Clinical success was present in 54 (100%) patients with claudication and in 65 of 78 (83%) patients with critical limb ischemia (CLI). Atherectomy in combination with DCB angioplasty can be safely performed in patients with complex, calcified peripheral lesions with a relatively low rate of bail-out stenting and promising clinical mid-term results.
German Clinical Trials Register: DRKS00016708.
Similar content being viewed by others
Change history
20 October 2021
A Correction to this paper has been published: https://doi.org/10.1007/s00380-021-01967-z
References
Gallino A, Aboyans V, Diehm C, Cosentino F, Stricker H, Falk E, Schouten O, Lekakis J, Amann-Vesti B, Siclari F, Poredos P, Novo S, Brodmann M, Schulte KL, Vlachopoulos C, De Caterina R, Libby P, Baumgartner I; European Society of Cardiology Working Group on Peripheral Circulation (2014) Non-coronary atherosclerosis. Eur Heart J 35 (17):1112–1129
Fowkes FGR, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, Norman PE, Sampson UKA, Williams LJ, Mensah GA, Criqui MH (2013) Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382(9901):1329–1340
Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FGR, Gillespie I, Ruckley CV, Raab GMm, (2010) Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg 51(5 Suppl):5S–17S
Fakhry F, Spronk S, van der Laan L, Wever JJ, Teijink JAW, Hoffmann WH, Smits TM, van Brussel JP, Stultiens GNM, Derom A, den Hoed T, Ho HG, van Dijk LC, Verhofstad N, Orsini M, van Petersen A, Woltman K, Hulst I, van Sambeek MRHM, Rizopoulos D, Rouwet EV, Hunink MGM (2015) Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. JAMA 314(18):1936–1944
Greenhalgh RM, Belch JJF, Brown LC, Gaines PA, Gao L, Reise JA, Thompson SG (2008) The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. Eur J Vasc Endovasc Surg 36(6):680–688
Agarwal S, Sud K, Shishehbor MH (2016) Nationwide trends of Hospital admission and outcomes among critical limb ischemia patients: from 2003–2011. J Am Coll Cardiol 67(16):1901–1913
Fitzgerald PJ, Ports TA, Yock PG (1992) Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation 86(1):64–70
Fanelli F, Cannavale A, Gazzetti M, Lucatelli P, Wlderk A, Cirelli C, d’Adamo A, Salvatori FM (2014) Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease. Cardiovasc Intervent Radiol 37(4):898–907
Lichtenberg M, Korosoglou G (2019) Atherectomy plus antirestenotic therapy for SFA lesions: evolving evidence for better patency rates in complex lesions. J Cardiovasc Surg (Torino) 60(2):205–211
Davis T, Ramaiah V, Niazi K, Martin Gissler H, Crabtree T (2017) Safety and effectiveness of the Phoenix Atherectomy System in lower extremity arteries: early and midterm outcomes from the prospective multicenter EASE study. Vascular 25(6):563–575
Giusca S, Lichtenberg M, Hagstotz S, Eisenbach C, Katus HA, Erbel C, Korosoglou G (2020) Comparison of ante-versus retrograde access for the endovascular treatment of long and calcified, de novo femoropopliteal occlusive lesions. Heart Vessels 35(3):346–359
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45(1):S5–67
Dattilo R, Himmelstein SI, Cuff RF (2014) The COMPLIANCE 360° Trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. J Invasive Cardiol 26(8):355–360
Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olim JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR (2001) Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286(11):1317–1324
Abu Dabrh AM, Steffen MW, Undavalli C, Asi N, Wang Z, Elamin MB, Conte MS, Murad MH (2015) The natural history of untreated severe or critical limb ischemia. J Vasc Surg 62(6):1642–1651
Aboyans V, Ricco J-B, Bartelink M-LEL, Björck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I (2018) 2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries endorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 39(9):763–816
Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Machan LS, Snyder SA, O’Leary EE, Ragheb AO, Zeller T (2016) Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial. Circulation 133(15):1472–1483
Shammas NW (2013) An overview of optimal endovascular strategy in treating the femoropopliteal artery: mechanical, biological, and procedural factors. Int J Angiol 22(1):1–8
Cambiaghi T, Spertino A, Bertoglio L, Chiesa R (2017) Fracture of a supera interwoven nitinol stent after treatment of popliteal artery stenosis. J Endovasc Ther 24(3):447–449
Laird JR (2011) Endovascular treatment of common femoral artery disease viable alternative to surgery or just another short-term fix. J Am Coll Cardiol 58(8):799–800
Nelson PR, Powell RJ, Schermerhorn ML, Fillinger MF, Zwolak RM, Walsh DB, Cronenwett JL (2002) Early results of external iliac artery stenting combined with common femoral artery endarterectomy. J Vasc Surg 35(6):1107–1113
Malgor RD, Ricotta JJ, Bower TC, Oderich GS, Kalra M, Duncan AA, Gloviczki P (2012) Common femoral artery endarterectomy for lower-extremity ischemia: evaluating the need for additional distal limb revascularization. Ann Vasc Surg 26(7):946–956
Korosoglou G, Giusca S, Andrassy M, Lichtenberg M (2019) The role of atherectomy in peripheral artery disease: current evidence and future perspectives. Vasc Endovasc Rev 2(1):12–18
Katsanos K, Spiliopoulos S, Reppas L, Karnabatidis D (2017) Debulking atherectomy in the peripheral arteries: Is there a role and what is the evidence? Cardiovasc Intervent Radiol 40(7):964–977
Gandini R, Pratesi G, Merolla S, Scaggiante J, Chegai F (2019) A single center experience with Phoenix Atherectomy System in patients with moderate-heavily calcified femoropopliteal lesions. Cardiovasc Revasc Med 21(5):676–681
McKinsey JF, Zeller T, Rocha-Singh KJ, Jaff MR, Garcia LA, DEFINITIVE LE Investigators (2014) Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study. JACC Cardiovasc Interv 7(8):923–933
Roberts D, Niazi K, Miller W, Krishnan P, Gammon R, Schreiber T, Shammas NW, Clair D, DEFINITIVE Ca++ Investigators (2014) Effective endovascular treatment of calcified femoropopliteal disease with directional atherectomy and distal embolic protection: final results of the DEFINITIVE Ca++ trial. Catheter Cardiovasc Interv 84(2):236–244
Safian RD, Niazi K, Runyon JP, Dulas D, Weinstock B, Ramaiah V, Heuser R, Investigators OASIS (2009) Orbital atherectomy for infrapopliteal disease: device concept and outcome data for the OASIS trial. Catheter Cardiovasc Interv 73(3):406–412
Das T, Mustapha J, Indes J, Vorhies R, Beasley R, Doshi N, Adams GL (2014) Technique optimization of orbital atherectomy in calcified peripheral lesions of the lower extremities: the CONFIRM series, a prospective multicenter registry. Catheter Cardiovasc Interv 83(1):115–122
Zeller T, Langhoff R, Rocha-Singh KJ, Jaff MR, Blessing E, Amann-Vesti B, Krzanowski M, Peeters P, Scheinert D, Torsello G, Sixt S, Tepe G, DEFINITIVE AR Investigators (2017) Directional atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circ Cardiovasc Interv 10(9):e004848
Katsanos K, Spiliopoulos S, Kitrou P, Krokidis M, Karnabatidis D (2018) Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 7(24):e011245
Gray WA, Jaff MR, Parikh SA, Ansel GM, Brodmann M, Krishnan P, Razavi MK, Vermassen F, Zeller T, White R, Ouriel K, Adelman MA, Lyden SP (2019) Mortality assessment of paclitaxel-coated balloons: patient-level meta-analysis of the ILLUMENATE Clinical Program at 3 years. Circulation 140(14):1145–1155
Freisinger E, Koeppe J, Gerss J, Goerlich D, Malyar NM, Marschall U, Faldum A, Reinecke H (2019) Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis. Eur Heart J. https://doi.org/10.1093/eurheartj/ehz698
Ouriel K, Adelman MA, Rosenfield K, Scheinert D, Brodmann M, Peña C, Geraghty P, Lee A, White R, Clair DG (2019) Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease. JACC Cardiovasc Interv 12:2515–2524
Funding
The GRN Hospital Weinheim (G.K. & S.G.) received an institutional research grant from Volcano, Philips.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The GRN Hospital Weinheim (G.K. & S.G.) received an institutional research grant from Volcano, Philips. No conflicts of interests to declare on behalf of all other authors of this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised due to appendix section was missing and included in this version.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Giusca, S., Lichtenberg, M., Schueler, M. et al. Safety, effectiveness and mid-term follow-up in 136 consecutive patients with moderate to severely calcified lesions undergoing phoenix atherectomy. Heart Vessels 36, 366–375 (2021). https://doi.org/10.1007/s00380-020-01695-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-020-01695-w